108 reports of this reaction
2.7% of all ACYCLOVIR SODIUM reports
#2 most reported adverse reaction
DYSPNOEA is the #2 most commonly reported adverse reaction for ACYCLOVIR SODIUM, manufactured by AuroMedics Pharma LLC. There are 108 FDA adverse event reports linking ACYCLOVIR SODIUM to DYSPNOEA. This represents approximately 2.7% of all 4,002 adverse event reports for this drug.
Patients taking ACYCLOVIR SODIUM who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DYSPNOEA is a less commonly reported adverse event for ACYCLOVIR SODIUM, but still significant enough to appear in the safety profile.
In addition to dyspnoea, the following adverse reactions have been reported for ACYCLOVIR SODIUM:
The following drugs have also been linked to dyspnoea in FDA adverse event reports:
DYSPNOEA has been reported as an adverse event in 108 FDA reports for ACYCLOVIR SODIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
DYSPNOEA accounts for approximately 2.7% of all adverse event reports for ACYCLOVIR SODIUM, making it one of the most commonly reported side effect.
If you experience dyspnoea while taking ACYCLOVIR SODIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.